MedTrace Logo

Tennis Elbow Trial

NCT00888225 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2009-04-27

No results posted yet for this study

Summary

Epi-X is a multicentered randomized controlled clinical trial of chronic lateral epicondylitis with parallel group design and two phases. In the first phase physical exercise treatment is given in the intervention group and expectance in the reference group. In phase 2 eccentric exercise versus concentric is tested.

Conditions

  • Lateral Epicondylitis

Interventions

PROCEDURE

Eccentric exercise

Eccentric exercise treatment performed at home with three sets of 15 repetitions daily

PROCEDURE

Concentric exercise

Concentric exercise treatment at home with three sets of 15 repetitions daily

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Amersham Foundation

    collaborator UNKNOWN

  • Uppsala County Council, Sweden

    collaborator OTHER_GOV

  • Uppsala University

    lead OTHER

Principal Investigators

  • Kurt Svärdsudd, MD, PhD · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2008-01-31
Completion
2008-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888225 on ClinicalTrials.gov